Home » Newsletters » BioWorld Science

BioWorld Science

April 15, 2010

View Archived Issues

Promising phase Ib data on TD-101 in pachyonychia congenita / News in Context

Targeting gut-derived serotonin synthesis shows therapeutic potential in osteoporosis

Suven Life Sciences discloses novel 5-HT6 receptor ligands

Novel antibacterial compounds identified by Korean scientists

Pfizer presents new 5-HT2C receptor agonists with antiobesity potential

Aeolus begins second preclinical study of AEOL-10150 for acute radiation syndrome

Proximagen grants Upsher-Smith rights to tonabersat for epilepsy in North America

Clinical data disclosed on gabapentin enacarbil in restless legs syndrome

Roche discloses new therapeutics for type 2 diabetes

Oral torezolid phosphate safe in phase II trial in complicated skin/skin structure infection

Merck & Co. presents novel CGRP receptor antagonists

Astellas claims new inhibitors of Rho-associated protein kinase

Malaysian scientists disclose new rosamine analogues for cancer therapy

RXi and miRagen to collaborate on miRNA-based agents

MolMed's NGR-hTNF enters phase III in malignant pleural mesothelioma

Neurocrine begins second phase I clinical trial of VAT2 inhibitor NBI-98854 in Canada

Roche acquires Medingo and expands position in insulin delivery systems market

Critical Outcome Technologies provides update on HIV-1 integrase program

InterMune reports topline phase IIb danoprevir data in hepatitis C

Mersana and Teva Pharmaceutical collaborate on development of XMT-1107

Catalyst signs agreement with NIDA for phase IIb vigabatrin trial for cocaine addiction

Aeras and Crucell begin phase II trial of tuberculosis vaccine in HIV-infected adults

Adeona reports data on Zinthionein ZC in Alzheimer's disease and mild cognitive impairment

FDA announces phaseout dates for CFC-containing inhalers

Metabolex and Takeda enter research collaboration for biological products

Popular Stories

23andme founder-led group outbids Regeneron for company
BioWorld
The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
Today's news in brief
BioWorld
BioWorld briefs for June 17, 2025.
Elevidys’ second liver death hits Sarepta, sends DMD ripples
BioWorld
How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 17, 2025.
EACR 2025: Immune rewiring in cancer orchestrates tumor microenvironment
BioWorld Science
Among the presentations included in the Top Abstracts category at the recently inaugurated Annual Congress of the European Association for Cancer Research (EACR)...